Entrada Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Entrada Therapeutics, Inc. has filed 471 SEC EDGAR filings since 10 Nov 2016

SEC filing history

Showing 301-325 of 471 matching filings.

Per page
25
Current page
13
4/A

FORM 4/A

Filing date
19 Apr 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
19 Apr 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
19 Apr 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40969

144 filing

Filing date
17 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Apr 2023
Reporting date
04 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
04 Apr 2023
Reporting date
04 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Mar 2023
Reporting date
27 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270286

FORM S-8

Filing date
06 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93025

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93025

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93025

SEC SCHEDULE 13G

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Jan 2023
Reporting date
27 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jan 2023
Reporting date
30 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .